Vancomycin-arginine (STM-001) abrogates ESBL carrier and carbapenem-resistant Escherichia coli burden in a murine complicated urinary tract infection modelJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62022-03-018OAAI
In Vivo Targeting of Escherichia coli with Vancomycin-ArginineANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52021-03-1821OAAI
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled TrialJOURNAL OF CLINICAL IMMUNOLOGYIF5.72015-04-1768PREAI
Survey of tuberculin skin test positivity among Israeli pediatric hospital workersINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32015-01-022PREAI
Distribution of fluconazole-resistant Candida bloodstream isolates among hospitals and inpatient services in IsraelCLINICAL MICROBIOLOGY AND INFECTIONIF8.52013-08-0119OA
ORAL ANTI-CD3 IMMUNOTHERAPY FOR HCV-NON-RESPONDERS IS SAFE, PROMOTES REGULATORY T CELLS, AND DECREASES VIRAL LOAD AND LIVER ENZYME LEVELS: RESULTS OF A PHASE-2a PLACEBO-CONTROLLED TRIALJOURNAL OF HEPATOLOGYIF332013-04-011PREAI
Targeted fluconazole prophylaxis for high-risk very low birth weight infants高危极低出生体重儿的目标氟康唑预防EUROPEAN JOURNAL OF PEDIATRICSIF2.62012-05-2511PREAI
Antibiotic Exposure as a Risk Factor for Fluconazole-Resistant Candida Bloodstream InfectionANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52012-05-01153OAAI
Containment of a Country-wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae in Israeli Hospitals via a Nationally Implemented InterventionCLINICAL INFECTIOUS DISEASESIF7.32011-02-11375PREAI
Moxifloxacin increases anti-tumor and anti-angiogenic activity of irinotecan in human xenograft tumorsBIOCHEMICAL PHARMACOLOGYIF5.62010-04-0118PREAI
Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in childrenEUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASESIF32009-11-1319PREAI
Identification of novel cell wall destabilizing antifungal compounds using a conditional Aspergillus nidulans protein kinase C mutantJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62009-07-3120OAAI
Transplanted hematopoietic cells seed in clusters in recipient bone marrow in vivoStem CellsIF3.62009-01-0141OAAI
Risk factors for sternal wound infection in children undergoing cardiac surgery: a case-control study儿童心脏手术胸骨切口感染危险因素的病例对照研究JOURNAL OF HOSPITAL INFECTIONIF3.12008-12-0132PREAI
Antibiotic use in 26 departments of internal medicine in 6 general hospitals in Israel: variability and contributing factorsJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62008-04-0927OAAI
Moxifloxacin but not ciprofloxacin or azithromycin selectively inhibits IL-8, IL-6, ERK1/2, JNK, and NF-κB activation in a cystic fibrosis epithelial cell lineAMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGYIF3.52007-01-0170PREAI
Moxifloxacin enhances antiproliferative and apoptotic effects of etoposide but inhibits its proinflammatory effects in THP-1 and Jurkat cellsBRITISH JOURNAL OF CANCERIF6.82006-10-1739OAAI
Anti-inflammatory effects of moxifloxacin on IL-8, IL-1β and TNF-α secretion and NFκB and MAP-kinase activation in human monocytes stimulated with Aspergillus fumigatusJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62005-12-1372OAAI
Moxifloxacin inhibits cytokine-induced MAP kinase and NF-κB activation as well as nitric oxide synthesis in a human respiratory epithelial cell lineJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62005-03-0138PREAI
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapyEUROPEAN RESPIRATORY JOURNALIF212005-02-0196OAAI